1. Rule 1: If the molecule contains a nitro group (-NO2), it is more likely to cause adverse effects.
2. Rule 2: If the molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is more likely to cause adverse effects.
3. Rule 3: If the molecule contains a ring structure, it is less likely to cause adverse effects.
These rules are based on the observation that molecules with nitro groups and halogen atoms are more likely to cause adverse effects, while molecules with ring structures are less likely to cause adverse effects. However, it is important to note that these rules are not always accurate and should be used as a starting point for further research and analysis.

================================

1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects.
2. Rule 2: The presence of a halogen atom (-F, -Cl, -Br, -I) in a molecule increases the likelihood of causing adverse effects.
3. Rule 3: The presence of a carbonyl group (-C=O) in a molecule increases the likelihood of causing adverse effects.
Explanation:
1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects. This is because nitro groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
2. Rule 2: The presence of a halogen atom (-F, -Cl, -Br, -I) in a molecule increases the likelihood of causing adverse effects. This is because halogen atoms can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
3. Rule 3: The presence of a carbonyl group (-C=O) in a molecule increases the likelihood of causing adverse effects. This is because carbonyl groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
Explanation:
1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects. This is because nitro groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
2. Rule 2: The presence of a halogen atom (-F, -Cl, -Br, -I) in a molecule increases the likelihood of causing adverse effects. This is because halogen atoms can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
3. Rule 3: The presence of a carbonyl group (-C=O) in a molecule increases the likelihood of causing adverse effects. This is because carbonyl groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.

================================

1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects.
2. Rule 2: The presence of a halogen atom (-Cl, -Br, -I) in a molecule increases the likelihood of causing adverse effects.
3. Rule 3: The presence of a carbonyl group (-C=O) in a molecule increases the likelihood of causing adverse effects.
These rules are based on the data provided and can be used to predict whether a molecule is likely to cause adverse effects based on its structure. However, it is important to note that these rules are not definitive and may not apply to all cases. It is always recommended to consult with a qualified chemist before making any decisions based on these rules.

================================

1. Rule 1: If the molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is more likely to cause adverse effects.
2. Rule 2: If the molecule contains a carbonyl group (such as a ketone or an aldehyde), it is more likely to cause adverse effects.
3. Rule 3: If the molecule contains a nitro group (such as a nitrite or a nitrate), it is more likely to cause adverse effects.
These rules are based on the fact that halogen atoms, carbonyl groups, and nitro groups are commonly found in molecules that are associated with adverse effects. However, it is important to note that these rules are not always accurate and should be used as a starting point for further research and analysis.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If a molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If a molecule contains a halogen atom (-Cl, -Br, -I), it is likely to cause adverse effects related to dermatological disorders.
3. Rule 3: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to neurological disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The first molecule, [Li+].[Li+].C(=O)([O-])[O-], contains a carbonyl group (-C=O) and is labeled as 0, which means it is not related to adverse effects related to hepatobiliary disorders. This suggests that the presence of a carbonyl group may not necessarily lead to adverse effects related to hepatobiliary disorders. However, it is important to note that this rule is based on a single example and may not be applicable to all molecules.
2. Rule 2: The second molecule, C[C@H](C(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCNC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(=O)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)N(C)C(=O)[C@H](CO)NC(=O)[C@@H](CC3=CN=CC=C3)NC(=O)[C@@H](CC4=CC=C(C=C4)Cl)NC(=O)[C@@H](CC5=CC6=CC=CC=C6C=C5)NC(=O)C, contains a halogen atom (-Cl) and is labeled as 0, which means it is not related to adverse effects related to dermatological disorders. This suggests that the presence of a halogen atom may

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to dermatological disorders.
3. Rule 3: If the molecule contains a sulfur atom (-S), it is likely to cause adverse effects related to respiratory disorders.
Explanation:
1. The first rule is based on the fact that nitro groups are commonly found in drugs that are associated with adverse effects related to hepatobiliary disorders. Nitro groups can interact with the liver and cause damage to the liver cells. Therefore, if a molecule contains a nitro group, it is likely to cause adverse effects related to hepatobiliary disorders.
2. The second rule is based on the fact that chlorine atoms are commonly found in drugs that are associated with adverse effects related to dermatological disorders. Chlorine atoms can interact with the skin and cause irritation, which can lead to adverse effects. Therefore, if a molecule contains a chlorine atom, it is likely to cause adverse effects related to dermatological disorders.
3. The third rule is based on the fact that sulfur atoms are commonly found in drugs that are associated with adverse effects related to respiratory disorders. Sulfur atoms can interact with the lungs and cause irritation, which can lead to adverse effects. Therefore, if a molecule contains a sulfur atom, it is likely to cause adverse effects related to respiratory disorders.

================================

1. Rule 1: If a molecule contains a carboxylic acid group, it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If a molecule contains a halogenated aromatic ring, it is likely to cause adverse effects related to hepatobiliary disorders.
3. Rule 3: If a molecule contains a nitro group, it is likely to cause adverse effects related to hepatobiliary disorders.
Explanation:
1. The first rule is based on the fact that carboxylic acid groups are commonly found in molecules that are associated with adverse effects related to hepatobiliary disorders. These molecules may disrupt the normal function of the liver and bile ducts, leading to liver damage and other health problems.
2. The second rule is based on the fact that halogenated aromatic rings are commonly found in molecules that are associated with adverse effects related to hepatobiliary disorders. These molecules may interact with the liver's enzymes and receptors, leading to liver damage and other health problems.
3. The third rule is based on the fact that nitro groups are commonly found in molecules that are associated with adverse effects related to hepatobiliary disorders. These molecules may interact with the liver's enzymes and receptors, leading to liver damage and other health problems.
Overall, these rules can be used to predict whether a molecule is likely to cause adverse effects related to hepatobiliary disorders based on its chemical structure.

================================

1. Rule 1: If the molecule contains a nitro group, it is likely to cause adverse effects.
2. Rule 2: If the molecule contains a chlorine atom, it is likely to cause adverse effects.
3. Rule 3: If the molecule contains a benzene ring, it is likely to cause adverse effects.
Explanation:
1. The first rule is based on the observation that nitro groups are commonly found in molecules that are associated with adverse effects. Nitro groups can cause liver damage, which is a common side effect of drugs. Therefore, if a molecule contains a nitro group, it is likely to cause adverse effects.
2. The second rule is based on the observation that chlorine atoms are commonly found in molecules that are associated with adverse effects. Chlorine atoms can cause skin irritation, which is a common side effect of drugs. Therefore, if a molecule contains a chlorine atom, it is likely to cause adverse effects.
3. The third rule is based on the observation that benzene rings are commonly found in molecules that are associated with adverse effects. Benzene rings can cause skin irritation, which is a common side effect of drugs. Therefore, if a molecule contains a benzene ring, it is likely to cause adverse effects.

================================

1. Rule 1: The presence of a carboxylic acid group (-COOH) in a molecule is a significant factor in predicting its potential to cause adverse effects.
2. Rule 2: The presence of a nitro group (-NO2) in a molecule is also a significant factor in predicting its potential to cause adverse effects.
3. Rule 3: The presence of a halogen atom (-Cl, -Br, -I) in a molecule is also a significant factor in predicting its potential to cause adverse effects.
Explanation:
1. Rule 1: The presence of a carboxylic acid group (-COOH) in a molecule is a significant factor in predicting its potential to cause adverse effects. This is because carboxylic acids are known to be highly reactive and can interact with biological molecules such as proteins and enzymes, which can lead to adverse effects.
2. Rule 2: The presence of a nitro group (-NO2) in a molecule is also a significant factor in predicting its potential to cause adverse effects. Nitro groups are also highly reactive and can interact with biological molecules, which can lead to adverse effects.
3. Rule 3: The presence of a halogen atom (-Cl, -Br, -I) in a molecule is also a significant factor in predicting its potential to cause adverse effects. Halogen atoms are also highly reactive and can interact with biological molecules, which can lead to adverse effects.

================================

1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects.
2. Rule 2: The presence of a halogen atom (-Cl, -Br, -I) in a molecule increases the likelihood of causing adverse effects.
3. Rule 3: The presence of a carbonyl group (-C=O) in a molecule increases the likelihood of causing adverse effects.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects related to hepatobiliary disorders.
2. Rule 2: The presence of a carbonyl group (-C=O) in a molecule increases the likelihood of causing adverse effects related to hepatobiliary disorders.
3. Rule 3: The presence of a chlorine atom (-Cl) in a molecule increases the likelihood of causing adverse effects related to hepatobiliary disorders.

================================

1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects.
2. Rule 2: The presence of a hydroxyl group (-OH) in a molecule increases the likelihood of causing adverse effects.
3. Rule 3: The presence of a halogen atom (-Cl, -Br, -I) in a molecule increases the likelihood of causing adverse effects.
Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects.
This rule is based on the observation that nitro compounds are known to be toxic and can cause adverse effects such as liver damage, respiratory distress, and methemoglobinemia. The presence of a nitro group in a molecule can increase the reactivity of the molecule and make it more toxic.
Rule 2: The presence of a hydroxyl group (-OH) in a molecule increases the likelihood of causing adverse effects.
This rule is based on the observation that hydroxyl compounds are known to be toxic and can cause adverse effects such as liver damage, respiratory distress, and methemoglobinemia. The presence of a hydroxyl group in a molecule can increase the reactivity of the molecule and make it more toxic.
Rule 3: The presence of a halogen atom (-Cl, -Br, -I) in a molecule increases the likelihood of causing adverse effects.
This rule is based on the observation that halogen compounds are known to be toxic and can cause adverse effects such as liver damage, respiratory distress, and methemoglobinemia. The presence of a halogen atom in a molecule can increase the reactivity of the molecule and make it more toxic.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is more likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a bromine atom (Br), it is less likely to cause adverse effects related to hepatobiliary disorders.
3. Rule 3: If the molecule contains a carbonyl group (C=O), it is more likely to cause adverse effects related to hepatobiliary disorders.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a chlorine atom (Cl), it is likely to cause adverse effects related to dermatological disorders.
3. Rule 3: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to gastrointestinal disorders.
These rules are based on the observation that the molecules with these functional groups are more likely to cause adverse effects than those without them. However, it is important to note that these rules are not foolproof and should be used with caution. It is always best to consult with a qualified chemist before making any decisions based on these rules.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is likely to cause adverse effects related to dermatological disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to gastrointestinal disorders.
These rules can be inferred by analyzing the labels and structures of the molecules in the data. For example, the molecule with label 1, "CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl", contains a nitro group (-NO2) and is likely to cause adverse effects related to hepatobiliary disorders. Similarly, the molecule with label 0, "CNC1=C(C=C(C=C1)C2=NC3=C(S2)C=C(C=C3)O)F", contains a halogen atom (fluorine) and is likely to cause adverse effects related to dermatological disorders. The molecule with label 0, "CN(C)CCOC1=CC=C(C=C1)CNC(=O)C2=CC(=C(C(=C2)OC)OC)OC", contains a carbonyl group (-C=O) and is likely to cause adverse effects related to gastrointestinal disorders.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to dermatological disorders.
3. Rule 3: If the molecule contains a benzene ring (C6H5), it is likely to cause adverse effects related to neurological disorders.
These rules can be inferred by analyzing the labels assigned to the smiles strings in the data. For example, the first rule can be inferred by analyzing the label assigned to the smiles string "CC1=C(C2=CC3=NC(=CC4=NC(=CC5=C(C(=C(N5)C=C1N2)C(C)OC(C)C6=C(C7=CC8=C(C(=C(N8)C=C9C(=C(C(=N9)C=C1C(=C(C(=N1)C=C6N7)C)CCC(=O)O)CCC(=O)O)C)C)C(C)O)C)C)C(=C4CCC(=O)O)C)C(=C3C)CCC(=O)O)C(C)O", which is 1. This smiles string is related to the side-effect activity of a molecule related to hepatobiliary disorders, and the presence of a nitro group (-NO2) in the molecule is likely to be the cause of this adverse effect. Similarly, the second and third rules can be inferred by analyzing the labels assigned to the smiles strings "CC1=NC(=O)C2=C(N1)C=CC(=C2)CN(C)C3=CC=C(S3)C(=O)N[C@@H](CCC(=O)O)C(=O)O" and "CC(C)(C)NCC(COC1=CC=CC=C1C2CCCC2C[C@H]1C(=O)O)O", respectively.

================================

1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects.
2. Rule 2: The presence of a halogen atom (such as fluorine, chlorine, or bromine) in a molecule increases the likelihood of causing adverse effects.
3. Rule 3: The presence of a carbonyl group (-C=O) in a molecule increases the likelihood of causing adverse effects.
These rules are based on the analysis of the given data and the observation that molecules with these functional groups are more likely to cause adverse effects. However, it is important to note that these rules are not definitive and may not apply to all cases. It is always recommended to consult with a qualified chemist before making any decisions based on these rules.

================================

1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects.
2. Rule 2: The presence of a chlorine atom (-Cl) in a molecule increases the likelihood of causing adverse effects.
3. Rule 3: The presence of a carbonyl group (-C=O) in a molecule increases the likelihood of causing adverse effects.
Explanation:
1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects. This is because nitro groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
2. Rule 2: The presence of a chlorine atom (-Cl) in a molecule increases the likelihood of causing adverse effects. Chlorine atoms can react with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
3. Rule 3: The presence of a carbonyl group (-C=O) in a molecule increases the likelihood of causing adverse effects. Carbonyl groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.

================================

1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects.
2. Rule 2: The presence of a halogen atom (-Cl, -Br, -I) in a molecule increases the likelihood of causing adverse effects.
3. Rule 3: The presence of a carbonyl group (-C=O) in a molecule increases the likelihood of causing adverse effects.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a halogenated aromatic ring, it is likely to cause adverse effects related to hepatobiliary disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to hepatobiliary disorders.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a halogen atom (-F, -Cl, -Br, -I), it is likely to cause adverse effects related to hepatobiliary disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to hepatobiliary disorders.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to hepatobiliary disorders.
3. Rule 3: If the molecule contains both a nitro group and a carboxylic acid group, it is likely to cause adverse effects related to hepatobiliary disorders.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to hepatobiliary disorders.
3. Rule 3: If the molecule contains a halogen atom (-F, -Cl, -Br, -I), it is likely to cause adverse effects related to hepatobiliary disorders.
These rules can be inferred from the given data as follows:
1. The first molecule, C(CC(=O)N)C(C(=O)O)N, contains a nitro group (-NO2) and is labeled as 1, which means it is related to the side-effect activity of a molecule related to hepatobiliary disorders.
2. The second molecule, C1CNC[C@@H]1N2CC/C(=C\C3=C(N4[C@@H]([C@@H](C4=O)NC(=O)/C(=C\5/NSC(=N5)N)/N=O)SC3)C(=O)O)/C2=O, contains a carbonyl group (-C=O) and is labeled as 0, which means it is not related to the side-effect activity of a molecule related to hepatobiliary disorders.
3. The third molecule, CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3, contains a halogen atom (-F) and is labeled as 0, which means it is not related to the side-effect activity of a molecule related to hepatobiliary disorders.
The fourth molecule, CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C, contains a halogen atom (-F) and is labeled as 0, which means it is not related to the side-effect activity of a molecule related to hepatobiliary disorders.
The fifth molecule, C1CN(CCC1O)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C#N 1, contains a halogen atom (-F) and is labeled as 1, which means it is related to the side-effect activity of a molecule related to hepatobiliary disorders.
The sixth molecule, CNC(=O)C1=CN(N=C1)C2=NC3=C(C(=N2)N)N=CN3[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O, contains a carbonyl group (-C=O) and is labeled as 0, which means it is not related to the side-effect activity of a molecule related to hepatobiliary disorders.
The seventh molecule, C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)COC(=O)C)O, contains a halogen atom (-F) and is labeled as 0, which means it is not related to the side-effect activity of a molecule related to hepatobiliary disorders.
The eighth molecule, COC(=O)CCC(=O)CN.Cl, contains a halogen atom (-Cl) and is labeled as 0, which means it is not related to the side-effect activity of a molecule related to hepatobiliary disorders.
The ninth molecule, [H+].[H+].CCOC1=CC=C(C=C1)C[C@@H](CN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-].[Gd+3], contains a halogen atom (-F) and is labeled as 0, which means it is not related to the side-effect activity of a molecule related to hepatobiliary disorders.
The tenth molecule, CCC[C@]1(CC(=O)C(=C(O1)[O-])[C@H](CC)C2=CC(=CC=C2)[N-]S(=O)(=O)C3=NC=C(C=C3)C(F)(F)F)CCC4=CC=CC=C4.[Na+].[Na+

================================

1. Rule 1: The presence of a carbonyl group (C=O) in a molecule is a significant indicator of its potential to cause adverse effects.
2. Rule 2: The presence of a nitro group (-NO2) in a molecule is also a significant indicator of its potential to cause adverse effects.
3. Rule 3: The presence of a halogen atom (such as fluorine, chlorine, or bromine) in a molecule is also a significant indicator of its potential to cause adverse effects.
These rules are based on the analysis of the given data and the observation that molecules with these functional groups are more likely to cause adverse effects than molecules without them. However, it is important to note that these rules are not absolute and there may be exceptions to them.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a chlorine atom, it is likely to cause adverse effects related to hepatobiliary disorders.
3. Rule 3: If the molecule contains a benzene ring, it is likely to cause adverse effects related to hepatobiliary disorders.

================================

1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects.
2. Rule 2: The presence of a hydroxyl group (-OH) in a molecule increases the likelihood of causing adverse effects.
3. Rule 3: The presence of a chlorine atom (-Cl) in a molecule increases the likelihood of causing adverse effects.
Explanation:
1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects. This is because nitro groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
2. Rule 2: The presence of a hydroxyl group (-OH) in a molecule increases the likelihood of causing adverse effects. This is because hydroxyl groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
3. Rule 3: The presence of a chlorine atom (-Cl) in a molecule increases the likelihood of causing adverse effects. This is because chlorine atoms can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
Explanation:
1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects. This is because nitro groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
2. Rule 2: The presence of a hydroxyl group (-OH) in a molecule increases the likelihood of causing adverse effects. This is because hydroxyl groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
3. Rule 3: The presence of a chlorine atom (-Cl) in a molecule increases the likelihood of causing adverse effects. This is because chlorine atoms can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
Explanation:
1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects. This is because nitro groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
2. Rule 2: The presence of a hydroxyl group (-OH) in a molecule increases the likelihood of causing adverse effects. This is because hydroxyl groups can interact with biological molecules such as proteins and enzymes, which can lead to toxicity and adverse effects.
3. Rule 3: The presence of a chlorine atom (-Cl) in a molecule increases the likelihood of causing adverse effects. This is because chlorine atoms can interact with biological molecules such as proteins and enzymes, which can lead

================================

1. Rule 1: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If a molecule contains a halogenated aromatic ring, it is likely to cause adverse effects related to hepatobiliary disorders.
3. Rule 3: If a molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to hepatobiliary disorders.

================================

1. Rule 1: If the molecule contains a nitro group, it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a chlorine atom, it is likely to cause adverse effects related to hepatobiliary disorders.
3. Rule 3: If the molecule contains a benzene ring, it is likely to cause adverse effects related to hepatobiliary disorders.
These rules are based on the observation that nitro groups, chlorine atoms, and benzene rings are commonly found in molecules that are associated with adverse effects related to hepatobiliary disorders. However, it is important to note that these rules are not definitive and should be used as a starting point for further research and analysis.

================================

1. Rule 1: If the molecule contains a functional group that is known to cause adverse effects in the liver and bile duct, such as an amidine group, then it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a functional group that is known to cause adverse effects in the skin, such as a sulfonamide group, then it is likely to cause adverse effects related to dermatological disorders.
3. Rule 3: If the molecule contains a functional group that is known to cause adverse effects in the nervous system, such as a piperazine group, then it is likely to cause adverse effects related to neurological disorders.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to hepatobiliary disorders.
2. Rule 2: If the molecule contains a chlorine atom, it is likely to cause adverse effects related to hepatobiliary disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to hepatobiliary disorders.

================================

